Bg pattern

RELPAX 20 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RELPAX 20 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

RELPAX 20mg film-coated tablets

Eletriptan

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Relpax and what is it used for
  2. What you need to know before you take Relpax
  3. How to take Relpax
  4. Possible side effects
  5. Storage of Relpax
  6. Contents of the pack and other information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Relpax and what is it used for

Relpax contains eletriptan as the active substance. Relpax belongs to a group of medicines called serotonin receptor agonists. Serotonin is a natural substance found in the brain that helps to narrow blood vessels.

Relpax can be used to treat migraine attacks with or without aura in adults. Before a migraine attack starts, you may experience a phase called "aura", in which you may have vision disturbances, numbness, and language problems.

2. What you need to know before you take Relpax

Do not takeRelpax:

  • If you are allergic (hypersensitive) to eletriptan or any of the other ingredients of this medicine (listed in section 6).
  • If you have severe liver or kidney disease.
  • If you have high blood pressure, moderate or severe, or if you have mild high blood pressure that is not being treated.
  • If you have had heart problems [such as a heart attack, angina, heart failure, or significant abnormalities in heart rhythm (arrhythmia), transient and sudden narrowing of one of the coronary arteries.
  • If you have poor circulation (peripheral vascular disease).
  • If you have ever had a stroke (even if it was mild and only lasted a few minutes or hours).
  • If you have taken ergotamine or ergotamine-type medications (including methysergide) within 24 hours before or after taking Relpax.
  • If you are taking other medications that end in "triptan" (such as sumatriptan, rizatriptan, naratriptan, zolmitriptan, almotriptan, and frovatriptan).

Tell your doctor and do not take Relpax if you currently have or have had any of these conditions.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Relpax if:

  • you have diabetes.
  • you smoke or are undergoing nicotine replacement therapy.
  • you are a male over 40 years old.
  • you are a postmenopausal woman.
  • you or a family member have coronary artery disease.
  • you have been informed that you may be at increased risk of heart disease, inform your doctor before taking Relpax.

Repeated use of migraine medications

If you repeatedly use Relpax or any other migraine medication for several days or weeks, this can cause long-lasting daily headaches. Tell your doctor if you have experienced this, as you may need to stop treatment for a while.

Use of Relpax with other medications

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medications.

Taking Relpax with some medications can cause serious side effects. Do not take Relpax if:

  • you have taken ergotamine or ergotamine-type medications (including methysergide) within 24 hours before or after taking Relpax.
  • you are taking other medications that end in "triptan" (such as sumatriptan, rizatriptan, naratriptan, zolmitriptan, almotriptan, and frovatriptan).

Some medications may affect how Relpax works, or Relpax may reduce the effectiveness of other medications taken at the same time. This includes:

  • Medications used to treat fungal infections (such as ketoconazole and itraconazole).
  • Medications used to treat bacterial infections (such as erythromycin, clarithromycin, and josamycin).
  • Medications used to treat HIV and AIDS (such as ritonavir, nelfinavir, and indinavir).

The herbal preparation containing St. John's Wort (Hypericum perforatum) should not be taken at the same time as this medicine. If you are already taking St. John's Wort, consult your doctor before stopping the St. John's Wort preparation.

Tell your doctor before starting treatment with eletriptan if you are taking certain medications (commonly known as SSRIs* or SNRIs**) for depression or other mental disorders. These medications may increase the risk of developing serotonin syndrome during combined use with certain migraine medications. See Section 4 "Possible side effects" for more information on the symptoms of serotonin syndrome.

*SSRIs – Selective serotonin reuptake inhibitors.

**SNRIs – Serotonin and norepinephrine reuptake inhibitors.

Taking Relpax with food and drinks

Relpax can be taken before or after eating and drinking.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medication.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

It is recommended to avoid breastfeeding for 24 hours after taking this medicine.

Driving and using machines

Relpax, or the migraine itself, can cause drowsiness. This medicine can also cause a feeling of dizziness. For this reason, you should avoid driving and using machines during the migraine attack or after taking the medicine.

Relpax contains lactose, yellow-orange aluminum lake (E110), and sodium

Lactose is a type of sugar. This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.

This medicine may cause allergic reactions because it contains yellow-orange aluminum lake (E110). It can cause asthma, especially in patients allergic to acetylsalicylic acid.

This medicine contains less than 23 mg of sodium (1mmol) per tablet; this is, essentially "sodium-free".

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Relpax

Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Adults

You can take the medicine at any time after the start of the migraine headache, but it is best to take it as soon as possible. However, you should only take Relpax during the headache phase of the migraine. Do not take this medicine to prevent a migraine attack.

  • The recommended initial dose is 40 mg (two 20 mg Relpax tablets or one 40 mg Relpax tablet) taken orally.
  • Take the tablet whole with a little water.
  • If the first tablet does not relieve your migraine, do not take a second tablet for the same attack.
  • If after taking the first tablet your migraine is relieved but then returns, you can take a second tablet. However, after taking the first tablet, you must wait at least 2 hours before taking the second tablet.
  • Do not take more than 80 mg (four 20 mg Relpax tablets or two 40 mg Relpax tablets) in 24 hours.
  • If with a dose of 40 mg (two 20 mg Relpax tablets or one 40 mg Relpax tablet) you do not get relief, consult your doctor. He will decide if you should increase the dose to 80 mg (four 20 mg Relpax tablets or two 40 mg Relpax tablets) in subsequent attacks.

Use in children and adolescents under 18 years

Relpax tablets are not recommended for use in children and adolescents under 18 years.

Elderly over 65 years

Relpax tablets are not recommended for use in patients over 65 years.

Renal impairment

This medicine can be used in patients with mild or moderate kidney problems. In these patients, the recommended initial dose is 20 mg (one 20 mg Relpax tablet) and the total daily dose should not exceed 40 mg (two 20 mg Relpax tablets or one 40 mg Relpax tablet).

Hepatic impairment

This medicine can be used in patients with mild or moderate liver problems. No dose adjustments are required for mild or moderate hepatic impairment.

If you take more Relpax than you should

If you accidentally take more Relpax than you should, contact your doctor immediately or go to the emergency department of the nearest hospital. Always take the medicine package with you, even if it is empty. The adverse effects of overdose with Relpax include high blood pressure and heart problems.

Consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.

It is recommended to take the medicine package and leaflet to the healthcare professional.

If you forget to take Relpax

If you forget to take a dose, take it as soon as you remember unless it is close to the time for the next dose. Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor immediatelyif you experience any of the following symptoms after taking the medicine.

  • Sudden wheezing, difficulty breathing, swelling of the eyelids, face, or lips, skin rash, or itching (especially affecting the whole body) as this may be a sign of hypersensitivity (allergy).
  • Chest pain and tightness, which can be intense and affect the throat. These can be symptoms of heart circulation problems (ischemic heart disease).
  • Signs and symptoms of serotonin syndrome, which can include restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, and overactive reflexes.

Other side effects that may occur are:

Common side effects:

(may affect up to 1 in 10 people)

  • Chest pain or tightness, heart palpitations, increased heart rate.
  • Dizziness, spinning sensation (vertigo), headache, numbness, decreased sense of touch or pain.
  • Sore throat, feeling of tightness in the throat, dry mouth.
  • Abdominal pain and stomach pain, indigestion (upset stomach), nausea (feeling of unease and discomfort in the stomach or abdomen that leads to vomiting).
  • Muscle stiffness (increased muscle tone), muscle weakness, back pain, muscle pain.
  • General feeling of weakness, feeling of heat, chills, runny nose, sweating, tingling or abnormal sensation, flushing, pain.

Uncommon side effects:

(may affect up to 1 in 100 people)

  • Difficulty breathing, yawning.
  • Swelling of the face or hands and feet, inflammation or infection of the tongue, skin rash, itching.
  • Increased sensitivity to touch or pain (hyperesthesia), loss of coordination, reduced or slowed movements, tremor, slurred speech.
  • Feeling of detachment from oneself (depersonalization), depression, abnormal thinking, feeling agitated, feeling confused, mood changes (euphoria), periods of unresponsiveness (stupor), general feeling of discomfort, illness, or malaise (malaise), sleep problems (insomnia).
  • Lack of appetite and weight loss (anorexia), taste disturbances, thirst.
  • Joint degeneration (osteoarthritis), bone pain, joint pain.
  • Increased need to urinate, urination problems, excessive urine, diarrhea.
  • Abnormal vision, eye pain, sensitivity to light, dry eyes or teary eyes.
  • Ear pain, ringing in the ears (tinnitus).
  • Poor circulation (peripheral vascular disorder).

Rare side effects:

(may affect up to 1 in 1,000 people)

  • Shock, asthma, hives, skin changes, swollen tongue.
  • Chest or throat infection, swollen lymph nodes.
  • Decreased heart rate.
  • Emotional fragility (mood changes).
  • Joint degeneration (arthritis), muscle disorder, twitching.
  • Constipation, esophagus inflammation, belching.
  • Breast pain, heavy or prolonged menstrual bleeding.
  • Eye infection (conjunctivitis).
  • Voice changes.

Other side effects reported include fainting, high blood pressure, large intestine inflammation, vomiting, blood vessel and brain accidents, inadequate blood flow to the heart, heart attack, artery and heart muscle spasms.

Your doctor may perform regular blood tests to check for increased liver enzymes or any blood problems.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Relpax

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of the month stated.

PVC/Aclar/Aluminum blisters: No special storage conditions are required.

HDPE bottles: Store in the original package. Keep the bottle tightly closed to protect from moisture.

Medicines should not be disposed of via wastewater or household waste. Return the packages and any unused medicines to the pharmacy's SIGRE collection point. If you have any doubts, ask your pharmacist how to dispose of packages and unused medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition of Relpax 20 mg film-coated tablets

The active substance is eletriptan (as eletriptan hydrobromide).

Each 20 mg Relpax film-coated tablet contains 20 mg of eletriptan (in the form of hydrobromide).

The other ingredients are: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, magnesium stearate, titanium dioxide (E-171), hypromellose, glycerol triacetate, and yellow-orange aluminum lake (E110) (see section 2).

Appearance of the product and pack contents

Relpax tablets are orange and round film-coated tablets.

Relpax 20 mg film-coated tablets are engraved with "VLE" on one side and "REP 20" on the other.

Relpax is available in opaque PVC/Aclar/Aluminum blisters containing 2, 3, 4, 5, 6, 10, 18, 30, and 100 tablets, or in HDPE bottles with a child-resistant HDPE/PP cap containing 30 and 100 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Viatris Healthcare, S.L.

Calle General Aranaz, 86, 3rd floor

28027 Madrid

Spain

Manufacturer

Pfizer Italia S.r.l.,

Località Marino del Tronto

63100 Ascoli Piceno

Italy

Local representative

Viatris Pharmaceuticals, S.L.U.

Calle General Aranaz, 86

28027 Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Relert 20 mg and 40 mg film-coated tablets: Belgium, Finland, Luxembourg, Portugal, Spain, United Kingdom.

Relpax 20 mg and 40 mg film-coated tablets: Austria, Denmark, France, Germany, Greece, Iceland, Ireland, Italy, Norway, Spain, Sweden, Netherlands, United Kingdom.

Date of last revision of this leaflet: January 2021

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for RELPAX 20 mg FILM-COATED TABLETS

Discuss questions about RELPAX 20 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for RELPAX 20 mg FILM-COATED TABLETS?
RELPAX 20 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RELPAX 20 mg FILM-COATED TABLETS?
The active ingredient in RELPAX 20 mg FILM-COATED TABLETS is eletriptan. This information helps identify medicines with the same composition but different brand names.
How much does RELPAX 20 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for RELPAX 20 mg FILM-COATED TABLETS is around 8.8 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures RELPAX 20 mg FILM-COATED TABLETS?
RELPAX 20 mg FILM-COATED TABLETS is manufactured by Viatris Healthcare Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RELPAX 20 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RELPAX 20 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RELPAX 20 mg FILM-COATED TABLETS?
Other medicines with the same active substance (eletriptan) include ELETRIPTAN AUROVITAS 20 mg FILM-COATED TABLETS, ELETRIPTAN AUROVITAS 40 mg FILM-COATED TABLETS, ELETRIPTAN BLUEFISH 20 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media